<DOC>
	<DOCNO>NCT01343407</DOCNO>
	<brief_summary>Part I study verify optimal execution procedure acquisition satisfactory sample utilize main study ( Part II ) ; drug administer . Part II ass effect multiple dose MK-1029 change allergen-induced sputum eosinophil change allergen-induced late asthmatic response ( LAR ) compare placebo .</brief_summary>
	<brief_title>A Two-part Study Effects MK-1029 Allergen-challenged Asthmatics ( MK-1029-003 AM1 )</brief_title>
	<detailed_description />
	<criteria>Parts I II Is male female nonchildbearing potential Has history allergeninduced asthma least 6 month Is judge good health ( asthma ) Is able perform reproducible pulmonary function testing Has positive methacholine challenge test Day 1 Has allergic response house dust mite allergen define positive skin prick test Is nonsmoker and/ use nicotine nicotinecontaining product least 12 month Has body mass index ( BMI ) ≥17 kg/m^2 , ≤33 kg/m^2 Part II Must demonstrate dual airway response allergen challenge Period 1 , decrease FEV1 least 20 % 0 2 hour allergen challenge early asthmatic response ( EAR ) positive late asthmatic response ( LAR ) inhale allergen challenge define bronchoconstrictive response least 15 % reduction FEV1 3 8 hour allergen challenge Can tolerate sputum induction produce adequate sputum Parts I II Has history illness , opinion study investigator , might confound result study pose additional risk participant Has recent ( 4 week ) ongoing upper low respiratory tract infection Is unable refrain anticipates use medication one permit study Has take oral , intramuscular , intraarticular , highpotency topical orally inhaled corticosteroid within 8 week Has take follow medication outside washout margin : nasal corticosteroid antileukotrienes within 3 week ; inhale longacting β2agonists , longacting antihistamine ( e.g. , loratadine , sustainedrelease agent ) , intranasal anticholinergic overthecounter decongestant within 1 week ; shortacting oral decongestant , shortacting antihistamine ( e.g. , chlorpheniramine ) within 48 hour Consumes excessive amount alcohol caffeinated beverage Has major surgery , donate lose 1 unit blood participate another investigational study within 3 month Has history severe allergy , anaphylactic reaction significant intolerability prescription nonprescription drug food Is nurse mother Has history receive antiimmunoglobulin E ( IgE ) immunotherapy Has history serious allergy drug history hypersensitivity mometasone furoate inactive ingredient lactose , inhaled salbutamol , antihistamine , potential asthma/anaphylaxis rescue medication Part II Has decline FEV1 70 % great post allergen diluent baseline and/or FEV1 &lt; 1.0L symptomatic drop FEV1 associate shortness breath unresolved bronchodilator within reasonable timeframe ( 60 minute ) allergen challenge study Period 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>